Global Atrial Fibrillation Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021) (By Procedures: Surgical Ablation- Mini Maze, Hybrid, Non-Surgical - Catheter; By Region-North America, Europe, APAC, ROW; By Country: U.S., Canada, UK, Germany, China, Japan)
Executive Summary
A comprehensive research report titled “Global Atrial Fibrillation (Afib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F)” created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, presents the analysis of the global atrial fibrillation or Afib market and has been segmented By Procedures (Surgical Ablation- Mini Maze, Hybrid, Non-Surgical – Catheter); By Region (North America, Europe, APAC, ROW) and By Country (U.S., Canada, UK, Germany, China, Japan).
Market for Afib is growing steadily on account of the rising number of Afib cases, which is caused by the lifestyle related diseases, such as hypertension, diabetes, obesity, and is gaining prominence among both adult and aged population. Rising cases of atrial fibrillation (Afib) among the population along with the growing focus on catheter ablation procedures has led to the growth of atrial fibrillation market.
Among the segments, market is expected to be driven by catheter ablation procedures on account of the technological improvement leading to higher success rates among the patients.
While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure, leading to increase in ablation centres and rising focus on healthcare among the growing middle class population.
Global Atrial Fibrillation Market is forecasted to grow at a CAGR of 13.26% during 2016 – 2021F, on account of rising Afib among the population. North America region remains the major market among all the regions. In the forecast period, APAC region will witness strong growth driven by the countries such as Japan and China.
According to Azoth Analytics research report, Global Atrial Fibrillation (Afib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F), Global Atrial Fibrillation market is projected to exhibit a CAGR of over ~13.26% during 2016 - 2021.
Scope of the Report
The report provides Segmentation by Procedures
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report titled “Global Atrial Fibrillation (Afib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F)” created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, presents the analysis of the global atrial fibrillation or Afib market and has been segmented By Procedures (Surgical Ablation- Mini Maze, Hybrid, Non-Surgical – Catheter); By Region (North America, Europe, APAC, ROW) and By Country (U.S., Canada, UK, Germany, China, Japan).
Market for Afib is growing steadily on account of the rising number of Afib cases, which is caused by the lifestyle related diseases, such as hypertension, diabetes, obesity, and is gaining prominence among both adult and aged population. Rising cases of atrial fibrillation (Afib) among the population along with the growing focus on catheter ablation procedures has led to the growth of atrial fibrillation market.
Among the segments, market is expected to be driven by catheter ablation procedures on account of the technological improvement leading to higher success rates among the patients.
While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure, leading to increase in ablation centres and rising focus on healthcare among the growing middle class population.
Global Atrial Fibrillation Market is forecasted to grow at a CAGR of 13.26% during 2016 – 2021F, on account of rising Afib among the population. North America region remains the major market among all the regions. In the forecast period, APAC region will witness strong growth driven by the countries such as Japan and China.
According to Azoth Analytics research report, Global Atrial Fibrillation (Afib) Market (Non-Surgical/Catheter, Surgical- Mini Maze, Hybrid): Analysis By Region, By Country (2016-2021F), Global Atrial Fibrillation market is projected to exhibit a CAGR of over ~13.26% during 2016 - 2021.
Scope of the Report
The report provides Segmentation by Procedures
- Surgical Ablation - Mini Maze, Hybrid
- Non-Surgical – Catheter
- North America
- Europe
- Asia Pacific
- ROW
- USA
- Canada
- UK
- Germany
- Japan
- China
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. PRODUCT OVERVIEW
5. GLOBAL ATRIAL FIBRILLATION MARKET OVERVIEW
5.1. Global Atrial Fibrillation Market, By Value ,Historic 2011-2015
5.2. Global Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
5.3. Global AF Ablation Market, By Procedure Types
5.3.1. Historic
5.3.2. Forecast
5.4. Global Atrial Fibrillation Market , By Region
5.4.1. Historic -2015(%)
5.4.2. Forecast -2021(%)
5.5. Global Non Surgical/Catheter AF Ablation Market, By Value, Historic 2011-2015
5.6. Global Non Surgical/Catheter AF Ablation Market, By Value, Forecast 2016E-2021F
5.7. Global Surgical AF Ablation Market, By Value, Historic 2011-2015
5.8. Global Surgical AF Ablation Market, By Value, Forecast 2016E-2021F
5.9. Global Surgical Atrial Fibrillation Market, By Procedure Types
5.9.1. Historic -2015(%)
5.9.2. Forecast -2021(%)
5.10. Global Mini Maze AF Ablation Market, By Value, Historic 2011-2015
5.11. Global Mini Maze AF Ablation Market, By Value, Forecast 2016E-2021F
5.12. Global Hybrid AF Ablation Market, By Value, Historic 2011-2015
5.13. Global Hybrid AF Ablation Market, By Value, Forecast 2016E-2021F
6. NORTH AMERICA ATRIAL FIBRILLATION MARKET OVERVIEW
6.1. North America Atrial Fibrillation Market, By Value, Historic 2011-2015
6.2. North America Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
6.3. North America Atrial Fibrillation Market, By Country
6.3.1. Historic -2015(%)
6.3.2. Forecast -2021(%)
6.4. United States Atrial Fibrillation Market, By Value, Historic 2011-2015
6.5. Unites States Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
6.6. Canada Atrial Fibrillation Market, By Value, Historic 2011-2015
6.7. Canada Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
7. EUROPE ATRIAL FIBRILLATION MARKET OVERVIEW
7.1. Europe Atrial Fibrillation Market, By Value, Historic 2011-2015
7.2. Europe Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
7.3. Europe Atrial Fibrillation Market, By Country
7.3.1.Historic -2015(%)
7.3.2.Forecast -2021(%)
7.4. Germany Atrial Fibrillation Market, By Value, Historic 2011-2015
7.5. Germany Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
7.6. United Kingdom Atrial Fibrillation Market, By Value, Historic 2011-2015
7.7. United Kingdom Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
8. ASIA PACIFIC ATRIAL FIBRILLATION MARKET OVERVIEW
8.1. Asia Pacific Atrial Fibrillation Market, By Value, Historic 2011-2015
8.2. Asia Pacific Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
8.3. Asia Pacific Atrial Fibrillation Market, By Country
8.3.1. Historic -2015(%)
8.3.2. Forecast -2021(%)
8.4. Japan Atrial Fibrillation Market, By Value, Historic 2011-2015
8.5. Japan Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
8.6. China Atrial Fibrillation Market, By Value, Historic 2011-2015
8.7. China Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
9. ROW ATRIAL FIBRILLATION MARKET OVERVIEW
9.1. ROW Atrial Fibrillation Market, By Value, Historic 2011-2015
9.2. ROW Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
10. MARKET TRENDS
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. POLICY AND REGULATORY LANDSCAPE
13. REIMBURSEMENT POLICIES
14. COMPANY PROFILING
14.1. St. Jude Medical
14.2. Medtronic
14.3. Boston Scientific Corporation
14.4. Atricure Inc.
14.5. Cardiofocus Inc.
14.6. Biosense Webster Inc.
14.7. Biotronik
14.8. TZ Medical
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. PRODUCT OVERVIEW
5. GLOBAL ATRIAL FIBRILLATION MARKET OVERVIEW
5.1. Global Atrial Fibrillation Market, By Value ,Historic 2011-2015
5.2. Global Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
5.3. Global AF Ablation Market, By Procedure Types
5.3.1. Historic
5.3.2. Forecast
5.4. Global Atrial Fibrillation Market , By Region
5.4.1. Historic -2015(%)
5.4.2. Forecast -2021(%)
5.5. Global Non Surgical/Catheter AF Ablation Market, By Value, Historic 2011-2015
5.6. Global Non Surgical/Catheter AF Ablation Market, By Value, Forecast 2016E-2021F
5.7. Global Surgical AF Ablation Market, By Value, Historic 2011-2015
5.8. Global Surgical AF Ablation Market, By Value, Forecast 2016E-2021F
5.9. Global Surgical Atrial Fibrillation Market, By Procedure Types
5.9.1. Historic -2015(%)
5.9.2. Forecast -2021(%)
5.10. Global Mini Maze AF Ablation Market, By Value, Historic 2011-2015
5.11. Global Mini Maze AF Ablation Market, By Value, Forecast 2016E-2021F
5.12. Global Hybrid AF Ablation Market, By Value, Historic 2011-2015
5.13. Global Hybrid AF Ablation Market, By Value, Forecast 2016E-2021F
6. NORTH AMERICA ATRIAL FIBRILLATION MARKET OVERVIEW
6.1. North America Atrial Fibrillation Market, By Value, Historic 2011-2015
6.2. North America Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
6.3. North America Atrial Fibrillation Market, By Country
6.3.1. Historic -2015(%)
6.3.2. Forecast -2021(%)
6.4. United States Atrial Fibrillation Market, By Value, Historic 2011-2015
6.5. Unites States Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
6.6. Canada Atrial Fibrillation Market, By Value, Historic 2011-2015
6.7. Canada Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
7. EUROPE ATRIAL FIBRILLATION MARKET OVERVIEW
7.1. Europe Atrial Fibrillation Market, By Value, Historic 2011-2015
7.2. Europe Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
7.3. Europe Atrial Fibrillation Market, By Country
7.3.1.Historic -2015(%)
7.3.2.Forecast -2021(%)
7.4. Germany Atrial Fibrillation Market, By Value, Historic 2011-2015
7.5. Germany Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
7.6. United Kingdom Atrial Fibrillation Market, By Value, Historic 2011-2015
7.7. United Kingdom Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
8. ASIA PACIFIC ATRIAL FIBRILLATION MARKET OVERVIEW
8.1. Asia Pacific Atrial Fibrillation Market, By Value, Historic 2011-2015
8.2. Asia Pacific Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
8.3. Asia Pacific Atrial Fibrillation Market, By Country
8.3.1. Historic -2015(%)
8.3.2. Forecast -2021(%)
8.4. Japan Atrial Fibrillation Market, By Value, Historic 2011-2015
8.5. Japan Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
8.6. China Atrial Fibrillation Market, By Value, Historic 2011-2015
8.7. China Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
9. ROW ATRIAL FIBRILLATION MARKET OVERVIEW
9.1. ROW Atrial Fibrillation Market, By Value, Historic 2011-2015
9.2. ROW Atrial Fibrillation Market, By Value, Forecast 2016E-2021F
10. MARKET TRENDS
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. POLICY AND REGULATORY LANDSCAPE
13. REIMBURSEMENT POLICIES
14. COMPANY PROFILING
14.1. St. Jude Medical
14.2. Medtronic
14.3. Boston Scientific Corporation
14.4. Atricure Inc.
14.5. Cardiofocus Inc.
14.6. Biosense Webster Inc.
14.7. Biotronik
14.8. TZ Medical
